Bd to sell surgical instrumentation platform to steris

Divestiture advances bd2025 strategy to simplify portfolio  and focus on higher-growth markets franklin lakes, n.j. , june 20, 2023 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced that it has signed a definitive agreement to sell its surgical instrumentation platform to steris (nyse: ste) for $540 million.
BDX Ratings Summary
BDX Quant Ranking